Approval marks Venus Remedies’ entry into Argentina for Ceftriaxone, taking total global MAs for the antibiotic to 39 Argentina is the 4th-largest pharmaceutical market in Latin America, valued at approximately US$7.3 billion in 2023 Approval strengthens Venus Remedies’ growing international anti infective portfolio amid rising burden of infectious
